Back to
RENAISSANCE TECHNOLOGIES LLC
ABCL21 quarters
Position history for
RENAISSANCE TECHNOLOGIES LLC's holdings in ABCELLERA BIOLOGICS INC
Yes. Renaissance Technologies holds 990,929 shares of ABCL (Abcellera Biologics), worth $7.8M, as of its Q2 2026 13F filing. It reduced the position by 519,700 shares (-34.4%) from Q1 2026. Renaissance Technologies has held ABCL since Q2 2021, across 21 quarterly 13F filings.
Current Value
$7.8M
Current Shares
990,929
Total Value Change
-$1.1M
Total Shares Change
+587,729
Quarter-by-Quarter History
Other major holders of ABCL: VIKING GLOBAL INVESTORS LP, BAKER BROS. ADVISORS LP, Capital World Investors